Charles River Laboratories®: a recognized leader in drug development
Charles River Laboratories® (CRL) has been instrumental in the development of over 80% of FDA-approved drugs in the past five years. Operating across 21 countries with over 150 facilities and a workforce of 21,000+ professionals, Charles River is a global leader in preclinical research. In 2024, they achieved $4.05 billion in revenue, demonstrating their financial strength and commitment to excellence.
Partnerships fueling innovation and research
Our partners are key to our success and ongoing progress. These collaborations leverage the expertise, global reach, and innovative research capabilities of our partners, driving the development of our groundbreaking therapy.
Strategic partnerships driving innovation
IQVIA™: the leading name in life science analytics & research
IQVIA™ is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA™ is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
Pepticom: AI-Driven Peptide Therapeutics Innovation
Pepticom is revolutionizing peptide-based drug discovery by leveraging cutting-edge AI and molecular modeling. Their proprietary platform combines principles from economic and molecular mechanics to design innovative peptides at atomic resolution, reduce time, costs, and the number of R&D candidates synthesized and tested.
Partnering for a healthier future
By aligning with industry leaders and adopting cutting edge technology, Aqur is positioned to bring transformative cholesterol therapies to millions worldwide. Our partnerships are more than collaborations — they are key drivers of medical breakthroughs. Together, we are shaping the future of cardiovascular health.
PHOTO: CHARLES RIVER LABORATORIES
Copyright © 2025 Aqur Biosciences, Inc. All rights reserved.
